Synthesis, aggregation, and neurotoxicity of the Alzheimer's Aβ1-42 amyloid peptide and its isoaspartyl isomers

被引:77
|
作者
Fukuda, H
Shimizu, T
Nakajima, M
Mori, H
Shirasawa, T
机构
[1] PE Biosyst Japan Ltd, Minato Ku, Tokyo 1060032, Japan
[2] Tokyo Metropolitan Inst Gerontol, Dept Mol Genet, Itabashi Ku, Tokyo 1730015, Japan
[3] Osaka City Univ, Sch Med, Dept Neurosci, Abeno Ku, Osaka 5458585, Japan
关键词
aggregation; Alzheimer's disease; beta-amyloid peptide; solid phase synthesis;
D O I
10.1016/S0960-894X(99)00121-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Amyloid A beta 1-42 peptide (A beta 1-42) and its isomers with an isoaspartyl residue at position 7 or 23 [A beta 1-42(isoAsp7) and A beta 1-42(isoAsp23)] were synthesized in high purity by the Fmoc-solid phase technique, followed by HPLC on a silica-based reversed-phase column under the basic conditions. Importantly, A beta 1-42(isoAsp23) aggregated more strongly than native A beta 1-42 and showed significant neurotoxicity, while the aggregation ability and neurotoxicity of A beta 1-42(isoAsp7) was weak. This suggests that the isomerization of the aspartyl residues plays an important role in fibril formation in Alzheimer's disease. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:953 / 956
页数:4
相关论文
共 50 条
  • [21] Alzheimer's β-amyloid peptide 1-42 induces a phagocytic response in murine microglia
    Kopec, KK
    Carroll, RT
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (05) : 2123 - 2131
  • [22] In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42)
    Yatin, SM
    Varadarajan, S
    Link, CD
    Butterfield, DA
    NEUROBIOLOGY OF AGING, 1999, 20 (03) : 325 - 330
  • [23] Synthesis of Alzheimer's (1-42) A beta-amyloid peptide with preformed Fmoc-aminoacyl fluorides
    Milton, SCF
    Milton, RCD
    Kates, SA
    Glabe, C
    TECHNIQUES IN PROTEIN CHEMISTRY VIII, 1997, 8 : 865 - 873
  • [24] Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1-42)
    Everett, J.
    Cespedes, E.
    Shelford, L. R.
    Exley, C.
    Collingwood, J. F.
    Dobson, J.
    van der Laan, G.
    Jenkins, C. A.
    Arenholz, E.
    Telling, N. D.
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2014, 11 (95)
  • [25] Emodin inhibits aggregation of amyloid-β peptide 1-42 and improves cognitive deficits in Alzheimer's disease transgenic mice
    Wang, Lichun
    Liu, Sitong
    Xu, Jiaqi
    Watanabe, Nobumoto
    Mayo, Kevin H.
    Li, Jiang
    Li, Xiaomeng
    JOURNAL OF NEUROCHEMISTRY, 2021, 157 (06) : 1992 - 2007
  • [26] Pregnenolone derivatives for the treatment of Alzheimer's disease: synthesis, and in vitro inhibition of amyloid β1-42 peptide aggregation, acetylcholinesterase and carbonic anhydrase-II
    Tahir, Ayesha
    Mobeen, Bushra
    Hussain, Fahad
    Sadiq, Abdul
    Rashid, Umer
    RSC ADVANCES, 2024, 14 (21) : 14742 - 14757
  • [27] Hydralazine inhibits amyloid beta (Aβ) aggregation and glycation and ameliorates Aβ1-42 induced neurotoxicity
    Batkulwar, Kedar B.
    Jana, Asis K.
    Godbole, Rashmi K.
    Khandelwal, Puneet
    Sengupta, Neelanjana
    Kulkarni, Mahesh J.
    RSC ADVANCES, 2016, 6 (110) : 108768 - 108776
  • [28] Influence of Hyperglycemic Conditions on Self-Association of the Alzheimer's Amyloid β (Aβ1-42) Peptide
    Menon, Sneha
    Sengupta, Neelanjana
    ACS OMEGA, 2017, 2 (05): : 2134 - 2147
  • [29] PEGylated phospholipid nanomicelles interact with β-amyloid(1-42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro
    Pai, Ashwini S.
    Rubinstein, Israel
    Onyuksel, Hayat
    PEPTIDES, 2006, 27 (11) : 2858 - 2866
  • [30] In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid β-peptide (1-42)
    Butterfield, DA
    Yatin, SM
    Link, CD
    OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS, 1999, 893 : 265 - 268